About

This is an excerpt from the report for demonstration purposes only.

AcademicResearch.jpg

Academic research

Galeazzi M, Gasbarrini G, Ghirardello A, Grandemange S, Hoffman HM, Manna R, Podswiadek M, Punzi L, Sebastiani GD, Touitou I, Doria A. Autoinflammatory syndromes. Clin Exp Rheumatol. 2006 Jan-Feb;24(1 Suppl 40):S79-85. Review. PMID:16466630

Hoffman HM, Wanderer AA. Inflammasome and IL-1beta-mediated disorders. Curr Allergy Asthma Rep. 2010 Jul;10(4):229-35. PMID:20425006

Hoffman HM. Rilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS). Expert Opin Biol Ther. 2009 Apr;9(4):519-31. Review. PMID:19344287

Martinon F, Mayor A, Tschopp J: The inflammasomes: guardians of the body. Annu Rev Immunol 2009, 27:229–265. This is an excellent review of inflammasome function.

Mertens M, Singh JA. Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol. 2009;36:1118–1125.

Hoffman HM. Rilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS) Expert Opin Biol Ther. 2009;9:519–531.

Savic S, McDermott MF. Inflammation: canakinumab for the cryopyrin-associated periodic syndromes. Nat Rev Rheumatol. 2009;5:529–530.

Aksentijevich I, Putnam CD, Remmers EF, et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007;56:1273–1285.